Suppr超能文献

评估与隐形眼镜相关的微生物性角膜炎:与疾病负担的相关性。

Grading contact lens-related microbial keratitis: relevance to disease burden.

作者信息

Keay Lisa, Edwards Katie, Dart John, Stapleton Fiona

机构信息

Institute for Eye Research and Vision Cooperative Research Centre and School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.

出版信息

Optom Vis Sci. 2008 Jul;85(7):531-7. doi: 10.1097/OPX.0b013e31817dba2e.

Abstract

PURPOSE

To describe a clinical grading system for epidemiological investigation of presumed contact lens related microbial keratitis (MK) and investigate the relationship to associated costs and disease duration.

METHODS

Eligible cases identified via surveillance required positive culture or presence of at least one clinical criterion: part of the lesion within the central 4 mm of the cornea, any anterior chamber reaction, or significant pain. Two reviewers graded cases as severe MK with vision loss (two lines), severe MK without vision loss (positive culture or central location, peripheral but >2 mm or with a hypopyon) or mild MK (remainder). The medical care, pathology, and medications comprised direct costs and loss of income, assistance of carers, and purchase of spectacles comprised indirect costs; these were calculated in Australian dollars (AU$). Duration of disease was estimated from duration of symptoms (days). Outcome measures were compared between categories using a one way analysis of variance (ANOVA).

RESULTS

There were 47 of 278 (16.3%) severe with vision loss, 137 of 278 (49.3%) severe without vision loss, and 94 of 278 (33.8%) mild MK. The disease duration was 18 (6 to 95) [median (inter-quartile range)] for severe cases with vision loss, 7 (4 to 14) for severe cases without vision loss, and 4 (3 to 7) days for mild MK (ANOVA, p < 0.001). Associated costs were AU$5515 (2784 to 9437) for severe cases with vision loss, AU$1596 (774 to 4888) for severe cases without vision loss, and AU$795 (527 to 1234) for the mild MK (ANOVA, p < 0.001). Costs and symptom duration were greatest for severe disease with vision loss, less for the severe disease without vision loss, and lowest for the mild disease (p < 0.003).

CONCLUSIONS

The comparison of disease burden lends support to this clinical grading system and the concept that the severity of MK can be stratified to identify those that might be of non-infectious etiology or have a microbial cause of low virulence with minimal morbidity.

摘要

目的

描述一种用于疑似与隐形眼镜相关的微生物性角膜炎(MK)流行病学调查的临床分级系统,并研究其与相关成本和疾病持续时间的关系。

方法

通过监测确定的符合条件的病例需要培养结果为阳性或存在至少一项临床标准:角膜中央4mm范围内的病变部分、任何前房反应或严重疼痛。两名审阅者将病例分为伴有视力丧失的重度MK(视力下降两行)、不伴有视力丧失的重度MK(培养结果阳性或病变位于中央、位于周边但>2mm或伴有前房积脓)或轻度MK(其余情况)。医疗护理、病理检查和药物构成直接成本,收入损失、护理人员协助和眼镜购买构成间接成本;这些成本以澳元(AU$)计算。疾病持续时间根据症状持续时间(天)估算。使用单因素方差分析(ANOVA)比较各分类之间的结果指标。

结果

278例中有47例(16.3%)为伴有视力丧失的重度MK,137例(49.3%)为不伴有视力丧失的重度MK,94例(33.8%)为轻度MK。伴有视力丧失的重度病例的疾病持续时间为18(6至95)[中位数(四分位间距)]天,不伴有视力丧失的重度病例为7(4至14)天,轻度MK为4(3至7)天(ANOVA,p<0.001)。伴有视力丧失的重度病例的相关成本为5515澳元(2784至9437),不伴有视力丧失的重度病例为1596澳元(774至4888),轻度MK为795澳元(527至1234)(ANOVA,p<0.001)。伴有视力丧失的重度疾病的成本和症状持续时间最高,不伴有视力丧失的重度疾病次之,轻度疾病最低(p<0.003)。

结论

疾病负担的比较支持了这种临床分级系统以及MK严重程度可分层的概念,以识别那些可能是非感染性病因或具有低毒力微生物病因且发病率最低的病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验